Phase ii trial of combined modality therapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Esophagogastric Junction Urothelium

Diseases77

Lung Neoplasms Hodgkin Disease Carcinoma, Non-Small-Cell Lung Carcinoma, Small Cell Adenocarcinoma Neoplasm Recurrence, Local Neoplasm Metastasis Neutropenia Disease Progression Leukopenia Nausea Neoplasms Thrombocytopenia Breast Neoplasms Brain Neoplasms Biliary Tract Neoplasms Kidney Neoplasms Carcinoma, Renal Cell Melanoma Colorectal Neoplasms Hematologic Diseases Peritoneal Neoplasms Ovarian Neoplasms Carcinoma, Squamous Cell Vomiting Pancreatic Neoplasms Head and Neck Neoplasms Prostatic Neoplasms Recurrence Glioblastoma Stomach Neoplasms Carcinoma Pleural Neoplasms Liver Neoplasms Fatigue Urologic Neoplasms Sarcoma Glioma Bone Neoplasms Diarrhea Exanthema Lymphoma, Non-Hodgkin Mesothelioma Carcinoma, Transitional Cell Vomiting, Anticipatory Soft Tissue Neoplasms Asthenia Stomatitis Esophageal Neoplasms Skin Neoplasms Drug-Related Side Effects and Adverse Reactions Anemia Neoplasms, Glandular and Epithelial Anorexia Drug Eruptions Neoplasms, Unknown Primary Rectal Neoplasms Lymphoma, Follicular Oligodendroglioma Lymphoma, T-Cell, Cutaneous Gallbladder Neoplasms Small Cell Lung Carcinoma Gastrointestinal Neoplasms Bone Marrow Diseases Urinary Bladder Neoplasms Gastrointestinal Diseases Nasopharyngeal Neoplasms Mycosis Fungoides Lymphatic Metastasis Peripheral Nervous System Diseases Lymphoma, Mantle-Cell Fallopian Tube Neoplasms Brain Stem Neoplasms Leukemia, Lymphocytic, Chronic, B-Cell Agranulocytosis Alopecia Leiomyosarcoma

Chemicals and Drugs94

Mechlorethamine Procarbazine Cisplatin Vincristine Fluorouracil Deoxycytidine Lomustine Antineoplastic Agents Paclitaxel Prednisone Taxoids Doxorubicin Cyclophosphamide Antineoplastic Agents, Phytogenic Carboplatin Antibodies, Monoclonal, Humanized Camptothecin Organoplatinum Compounds Antimetabolites, Antineoplastic Dacarbazine Vinblastine Quinazolines Leucovorin Antibodies, Monoclonal Antineoplastic Agents, Alkylating Tegafur Benzenesulfonates Epothilones Etoposide Oxonic Acid Phenylurea Compounds Ifosfamide Niacinamide Estramustine Thalidomide Angiogenesis Inhibitors Guanine Placebos Epirubicin Antibodies, Monoclonal, Murine-Derived Pyridines Interferon-alpha Protein Kinase Inhibitors Mesna Glutamates Prostate-Specific Antigen Antibiotics, Antineoplastic Topotecan Pyrazines Drug Combinations Boronic Acids Granulocyte Colony-Stimulating Factor Tumor Markers, Biological Pyrroles Vidarabine Phosphate Mitoxantrone Anthracyclines Platinum Compounds Bridged Compounds Nitrogen Mustard Compounds Recombinant Proteins Pyrimidines Cancer Vaccines Biomarkers, Pharmacological Drugs, Investigational Benzamides Receptor, Epidermal Growth Factor Depsipeptides Indoles Receptor, erbB-2 Dexamethasone Bryostatins Uracil Carmustine Mitomycin Isotretinoin Piperazines Mitotane Interleukin-2 Sirolimus Thymus Extracts Antineoplastic Agents, Hormonal Methotrexate Pyrazoles Polyethylene Glycols Cytarabine Melphalan Platinum Sulfonamides Piperidines Thiophenes Cladribine Yttrium Radioisotopes CA-125 Antigen

Analytical, Diagnostic and Therapeutic Techniques and Equipment70

Combined Modality Therapy Clinical Trials, Phase II as Topic Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Drug Administration Schedule Clinical Trials as Topic Survival Analysis Disease-Free Survival Survival Rate Infusions, Intravenous Radiotherapy Neoplasm Staging Drug Evaluation Radiotherapy Dosage Actuarial Analysis Radiotherapy, Adjuvant Chemotherapy, Adjuvant Prognosis Follow-Up Studies Clinical Trials, Phase III as Topic Maximum Tolerated Dose Salvage Therapy Administration, Oral Clinical Trials, Phase I as Topic Research Design Kaplan-Meier Estimate Remission Induction Neoadjuvant Therapy Double-Blind Method Prospective Studies Endpoint Determination Feasibility Studies Early Termination of Clinical Trials Patient Selection Treatment Failure Sample Size Placebos Multicenter Studies as Topic Dose Fractionation Chemoradiotherapy Karnofsky Performance Status Injections, Subcutaneous Randomized Controlled Trials as Topic Injections, Intravenous Induction Chemotherapy Area Under Curve Pilot Projects Drug Therapy, Combination Radioimmunotherapy Clinical Protocols Palliative Care Magnetic Resonance Imaging Infusions, Parenteral Controlled Clinical Trials as Topic Tomography, X-Ray Computed Risk Assessment Administration, Intravenous Immunotherapy Single-Blind Method Severity of Illness Index Molecular Targeted Therapy Premedication Retrospective Studies Probability Radiotherapy, Conformal Injections, Intralesional Transplantation, Autologous Retreatment Positron-Emission Tomography Risk Factors

Phenomena and Processes7

Maximum Tolerated Dose Dose-Response Relationship, Drug Metabolic Detoxication, Phase II Time Factors Drug Resistance, Neoplasm Area Under Curve Probability

Disciplines and Occupations2

Research Design Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life Survival

Technology, Industry, Agriculture1

Polyethylene Glycols

Humanities1

Quality of Life

Information Science2

Survival Rate Radiotherapy, Conformal

Health Care33

Clinical Trials, Phase II as Topic Treatment Outcome Clinical Trials as Topic Survival Analysis Disease-Free Survival Survival Rate Actuarial Analysis Follow-Up Studies Clinical Trials, Phase III as Topic Clinical Trials, Phase I as Topic Kaplan-Meier Estimate Double-Blind Method Prospective Studies Feasibility Studies Early Termination of Clinical Trials Patient Selection Treatment Failure Sample Size Multicenter Studies as Topic Karnofsky Performance Status Randomized Controlled Trials as Topic Safety Area Under Curve Pilot Projects Clinical Protocols Palliative Care Controlled Clinical Trials as Topic Risk Assessment Single-Blind Method Severity of Illness Index Retrospective Studies Probability Risk Factors

Geographicals1

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Combined Modality Therapy Clinical Trials, Phase II as Topic Antineoplastic Combined Chemotherapy Protocols Mechlorethamine Procarbazine Treatment Outcome Drug Administration Schedule Clinical Trials as Topic Survival Analysis Disease-Free Survival Cisplatin Lung Neoplasms Hodgkin Disease Vincristine Fluorouracil Deoxycytidine Survival Rate Lomustine Infusions, Intravenous Radiotherapy Antineoplastic Agents Neoplasm Staging Drug Evaluation Radiotherapy Dosage Paclitaxel Prednisone Taxoids Carcinoma, Non-Small-Cell Lung Carcinoma, Small Cell Doxorubicin Actuarial Analysis Adenocarcinoma Cyclophosphamide Radiotherapy, Adjuvant Chemotherapy, Adjuvant Antineoplastic Agents, Phytogenic Prognosis Neoplasm Recurrence, Local Carboplatin Neoplasm Metastasis Antibodies, Monoclonal, Humanized Follow-Up Studies Clinical Trials, Phase III as Topic Camptothecin Organoplatinum Compounds Neutropenia Antimetabolites, Antineoplastic Maximum Tolerated Dose Salvage Therapy Administration, Oral Dacarbazine Clinical Trials, Phase I as Topic Disease Progression Vinblastine Research Design Dose-Response Relationship, Drug Leukopenia Quinazolines Metabolic Detoxication, Phase II Nausea Leucovorin Antibodies, Monoclonal Kaplan-Meier Estimate Neoplasms Remission Induction Thrombocytopenia Antineoplastic Agents, Alkylating Neoadjuvant Therapy Tegafur Time Factors Benzenesulfonates Epothilones Breast Neoplasms Etoposide Brain Neoplasms Oxonic Acid Double-Blind Method Prospective Studies Phenylurea Compounds Endpoint Determination Biliary Tract Neoplasms Ifosfamide Niacinamide Drug Resistance, Neoplasm Kidney Neoplasms Estramustine Carcinoma, Renal Cell Melanoma Colorectal Neoplasms Thalidomide Hematologic Diseases Feasibility Studies Peritoneal Neoplasms Ovarian Neoplasms Carcinoma, Squamous Cell Angiogenesis Inhibitors Early Termination of Clinical Trials Vomiting Guanine Pancreatic Neoplasms

No FAQ available that match "phase ii trial of combined modality therapy"